Drug-mediated inhibition of Fli-1 for the treatment of leukemia

The Ets transcription factor, Fli-1 is activated in murine erythroleukemia and overexpressed in various human malignancies including Ewing's sarcoma, induced by the oncogenic fusion protein EWS/Fli-1. Recent studies by our group and others have demonstrated that Fli-1 plays a key role in tumorigenesis, and disrupting its oncogenic function may serve as a potential treatment option for malignancies associated with its overexpression. Herein, we describe the discovery of 30 anti-Fli-1 compounds, characterized into six functional groups. Treatment of murine and human leukemic cell lines with select compounds inhibits Fli-1 protein or mRNA expression, resulting in proliferation arrest and apoptosis. This anti-cancer effect was mediated, at least in part through direct inhibition of Fli-1 function, as anti-Fli-1 drug treatment inhibited Fli-1 DNA binding to target genes, such as SHIP-1 and gata-1, governing hematopoietic differentiation and proliferation. Furthermore, treatment with select Fli-1 inhibitors revealed a positive relationship between the loss of DNA-binding activity and Fli-1 phosphorylation. Accordingly, anti-Fli-1 drug treatment significantly inhibited leukemogenesis in a murine erythroleukemia model overexpressing Fli-1. This study demonstrates the ability of this drug-screening strategy to isolate effective anti-Fli-1 inhibitors and highlights their potential use for the treatment of malignancies overexpressing this oncogene

Dynamics-dependent density distribution in active suspensions

Self-propelled colloids constitute an important class of intrinsically non-equilibrium matter. Typically, such a particle moves ballistically at short times, but eventually changes its orientation, and displays random-walk behavior in the long-time limit. Theory predicts that if the velocity of non-interacting swimmers varies spatially in 1D, $v(x)$, then their density $\rho(x)$ satisfies $\rho(x) = \rho(0)v(0)/v(x)$, where $x = 0$ is an arbitrary reference point. Such a dependence of steady-state $\rho(x)$ on the particle dynamics, which was the qualitative basis of recent work demonstrating how to `paint' with bacteria, is forbidden in thermal equilibrium. We verify this prediction quantitatively by constructing bacteria that swim with an intensity-dependent speed when illuminated. A spatial light pattern therefore creates a speed profile, along which we find that, indeed, $\rho(x)v(x) = \mathrm{constant}$, provided that steady state is reached

A Large Gene Network in Immature Erythroid Cells Is Controlled by the Myeloid and B Cell Transcriptional Regulator PU.1

PU.1 is a hematopoietic transcription factor that is required for the development of myeloid and B cells. PU.1 is also expressed in erythroid progenitors, where it blocks erythroid differentiation by binding to and inhibiting the main erythroid promoting factor, GATA-1. However, other mechanisms by which PU.1 affects the fate of erythroid progenitors have not been thoroughly explored. Here, we used ChIP-Seq analysis for PU.1 and gene expression profiling in erythroid cells to show that PU.1 regulates an extensive network of genes that constitute major pathways for controlling growth and survival of immature erythroid cells. By analyzing fetal liver erythroid progenitors from mice with low PU.1 expression, we also show that the earliest erythroid committed cells are dramatically reduced in vivo. Furthermore, we find that PU.1 also regulates many of the same genes and pathways in other blood cells, leading us to propose that PU.1 is a multifaceted factor with overlapping, as well as distinct, functions in several hematopoietic lineages

A Key Commitment Step in Erythropoiesis Is Synchronized with the Cell Cycle Clock through Mutual Inhibition between PU.1 and S-Phase Progression

During red blood cell development, differentiation and cell cycle progression are intimately and uniquely linked through interdependent mechanisms involving the erythroid transcriptional suppressor PU.1 and the cyclin-dependent kinase inhibitor p57KIP2

A Scheme of Read-Out Organization for the ATLAS High-Level Triggers and DAQ based on ROB Complexes

This paper describes a possible organization of the ATLAS High-LevelTriggers and DAQ read-out system downstream the Read-Out Drivers. Itis based on the ROB Complex concept which assumes that each read-outunit is formed by several input buffer modules sharing a networkinterface to a common Trigger/DAQ data collection network. Animplementation of such ROB Complex based on PCI bus to connectread-out buffers, a control processor and a network interface cardis presented. The total number of ROB Complexes required for ATLAS,as well as the number of CompactPCI crates housing them are estimated.The results obtained from measurements on a ROB Complex prototypeintegrated in the ATLAS Level 2 Trigger ATM Testbed are given. Thefeasibility of some data preprocessing within a ROB Complex is shown